ADPT Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.32
Previous CloseN/A
Volume1.17K
Average Volume (3M)6.67K
Market Cap
C$655.91K
Enterprise ValueC$1.27
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding4,099,425
10 Day Avg. Volume5,300
30 Day Avg. Volume6,665
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Adaptogenics Health Corp. News
ADPT FAQ
What was Adaptogenics Health Corp.’s price range in the past 12 months?
Adaptogenics Health Corp. lowest stock price was C$0.06 and its highest was C$0.32 in the past 12 months.
What is Adaptogenics Health Corp.’s market cap?
Adaptogenics Health Corp.’s market cap is C$655.91K.
When is Adaptogenics Health Corp.’s upcoming earnings report date?
Adaptogenics Health Corp.’s upcoming earnings report date is Aug 20, 2026 which is in 12 days.
How were Adaptogenics Health Corp.’s earnings last quarter?
Adaptogenics Health Corp. released its earnings results on Jun 26, 2026. The company reported -C$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Adaptogenics Health Corp. overvalued?
According to Wall Street analysts Adaptogenics Health Corp.’s price is currently Overvalued.
Does Adaptogenics Health Corp. pay dividends?
Adaptogenics Health Corp. does not currently pay dividends.
What is Adaptogenics Health Corp.’s EPS estimate?
Adaptogenics Health Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adaptogenics Health Corp. have?
Adaptogenics Health Corp. has 4,099,425 shares outstanding.
What happened to Adaptogenics Health Corp.’s price movement after its last earnings report?
Adaptogenics Health Corp. reported an EPS of -C$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Adaptogenics Health Corp.?
Currently, no hedge funds are holding shares in TSE:ADPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Adaptogenics Health Corp.
Adaptogenics Health Corp. is a Canada-based nutraceutical company. The Company is focused on the formulation and distribution of functional mushroom products and nutritional supplement alternatives. It creates product formulations combining functional mushrooms and their adaptogens, which supports holistic health. The Company intends to launch five mushroom liquid tonics, including Reishi, Chaga, Turkey Tail, Lions Mane and Cordyceps (Cultured Chinese Caterpillar Fungus). The Company sells its products directly to consumers through Website as well as wholesaling to retailers throughout Canada.
Technical Analysis
Britannia Life Sciences Inc
―
BetterLife Pharma
―
HAVN Life Sciences
―
Glow LifeTech
―
―
